1. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the united states. results from the national comorbidity survey.;RC Kessler;Archives of General Psychiatry,1994
2. The epidemiology of anxiety disorders: prevalence and societal costs.;J Lépine;The Journal of Clinical Psychiatry,2002
3. An approach to the patient with anxiety.;D Hicks;The Medical Clinics of North America 94: 1127–1139,,2010
4. Diagnostic and Statistical Manual of Mental Disorders DSM-IV-TR Fourth Edition.;AP Association,2000
5. Predictors of pharmacotherapy response in anxiety disorders.;D Denys;Curr Psychiatry Rep,2005